Resources from the same session
LBA47 - Nivolumab plus ipilimumab and ASTX727 or nivolumab plus ipilimumab in PD-1 resistant metastatic melanoma: Primary analysis of the randomized phase II NIBIT-ML1 study
Presenter: Anna Di Giacomo
Session: Mini oral session: Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA46, 1080MO, 1081MO and LBA47
Presenter: Bart Neyns
Session: Mini oral session: Melanoma and other skin tumours
Resources:
Slides
Webcast